Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
The Journal of Pathology. Clinical Research
|
August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Nature Communications
|
April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Cancer
|
December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Eun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
The Journal of Pathology. Clinical Research
|
August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Nature Communications
|
April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Cancer
|
December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Eun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Page
of 10